Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis

Daniel A. Ermann, Victoria A. Vardell, Avyakta Kallam, Peter T. Silberstein, James O. Armitage

Research output: Contribution to journalArticle

Abstract

Diffuse large B-cell lymphoma is associated with varying outcomes, and disparities exist within high-risk disease. Prognostication with the International Prognostic Index anticipates patient outcomes, provides risk stratification, and guides treatment. We used a national database to compare the treatment outcomes from academic and nonacademic centers. We found improved overall survival in each risk category at academic centers.

Original languageEnglish (US)
Pages (from-to)e174-e183
JournalClinical Lymphoma, Myeloma and Leukemia
Volume20
Issue number4
DOIs
StatePublished - Apr 2020

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis'. Together they form a unique fingerprint.

  • Cite this